Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

Atbasoglu, E.; GÜMÜŞ AKAY, GÜVEM; Guloksuz, Sinan; SAKA, MERAM; Ucok, Alp; ALPTEKİN, KÖKSAL; GÜLLÜ, SEVİM; van Os, Jim

doi:10.1007/s00213-017-4818-z

Higher schizotypy predicts better metabolic profile in unaffected siblings of patients with schizophrenia

Atbasoglu E. C., GÜMÜŞ AKAY G., Guloksuz S., SAKA M. C., Ucok A., ALPTEKİN K., ...Daha Fazla

PSYCHOPHARMACOLOGY, cilt.235, sa.4, ss.1029-1039, 2018 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 235 Sayı: 4
Basım Tarihi: 2018
Doi Numarası: 10.1007/s00213-017-4818-z
Dergi Adı: PSYCHOPHARMACOLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1029-1039
Anahtar Kelimeler: Dopamine, Genetics, Insulin resistance, Schizophrenia, Schizotypy, Type 2 diabetes mellitus, DRUG-NAIVE PATIENTS, 1ST-EPISODE SCHIZOPHRENIA, NEUROTROPHIC FACTOR, INSULIN-RESISTANCE, GLUCOSE-TOLERANCE, DIABETES-MELLITUS, PSYCHOSIS, ASSOCIATION, HOMEOSTASIS, PREVALENCE
Ankara Üniversitesi Adresli: Evet

Özet

Type 2 diabetes (T2D) is more frequent in schizophrenia (Sz) than in the general population. This association is partly accounted for by shared susceptibility genetic variants.